NCT04014569View on ClinicalTrials.gov

Determination of Automated Multiple Insulin Dose Injections Settings Using the MDI/SMBG Advisor for Patients With Type 1 Diabetes -Data Collection, Observational & Proof of Concept Study

NATerminatedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

May 2, 2018

Primary Completion Date

September 1, 2020

Study Completion Date

September 1, 2020

Conditions
Type 1 DiabetesMultiple Daily Injections
Interventions
DEVICE

MPSA Algorithm

Insulin dosing will be adjusted using the MPSA Algorithm

Trial Locations (1)

Unknown

Schnider children medical center, Petah Tikva

Sponsors

Collaborators (1)

DreaMed
All Listed Sponsors
collaborator

DreaMed

INDUSTRY

collaborator

Harvard University

OTHER

lead

Rabin Medical Center

OTHER

NCT04014569 - Determination of Automated Multiple Insulin Dose Injections Settings Using the MDI/SMBG Advisor for Patients With Type 1 Diabetes -Data Collection, Observational & Proof of Concept Study | Biotech Hunter | Biotech Hunter